Key result
Intramuscular administration of t-PA facilitated by hydroxylamine and electrical stimulation markedly increased peak blood levels to 431 ng/ml at 5 minutes and elicited prompt coronary thrombolysis.
Why the study?
Does facilitated intramuscular injection of t-PA improve absorption and induce coronary thrombolysis in preclinical models?
Population
Preclinical models (rabbits and dogs)
Design
Preclinical
Follow-up
5 min (for peak blood levels)
Authors
Loading...
Does not support clinical use in AMI; leaves open translation of facilitated IM t-PA from animal models.
Does facilitated intramuscular injection of t-PA improve absorption and induce coronary thrombolysis in preclinical models?
Absolute Event Rate: 431% vs 8%
p-value: p=<0.01
Facilitated intramuscular injection of t-PA achieves rapid therapeutic blood levels and coronary thrombolysis in animal models, suggesting a potential approach for prompt self-medication in acute myocardial infarction.
Sobel et al. (1985) studied Coronary thrombosis (n=56). Intramuscular t-PA with hydroxylamine and electrical stimulation vs. Intramuscular t-PA in buffer alone was evaluated on Peak plasma t-PA concentration at 5 minutes (ng/ml) (p=<0.01). Intramuscular administration of t-PA facilitated by hydroxylamine and electrical stimulation markedly increased peak blood levels to 431 ng/ml at 5 minutes and elicited prompt coronary thrombolysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: